ATE290402T1 - Mononukleare phagozyten zur verabreichung von therapeutischen arzneimitteln - Google Patents
Mononukleare phagozyten zur verabreichung von therapeutischen arzneimittelnInfo
- Publication number
- ATE290402T1 ATE290402T1 AT97943993T AT97943993T ATE290402T1 AT E290402 T1 ATE290402 T1 AT E290402T1 AT 97943993 T AT97943993 T AT 97943993T AT 97943993 T AT97943993 T AT 97943993T AT E290402 T1 ATE290402 T1 AT E290402T1
- Authority
- AT
- Austria
- Prior art keywords
- administration
- mononuclear phagocytes
- therapeutic drugs
- mononuclear
- phagocytes
- Prior art date
Links
- 229940126585 therapeutic drug Drugs 0.000 title abstract 2
- 210000001539 phagocyte Anatomy 0.000 title 1
- 210000002864 mononuclear phagocyte Anatomy 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 230000005012 migration Effects 0.000 abstract 1
- 238000013508 migration Methods 0.000 abstract 1
- 230000001617 migratory effect Effects 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- External Artificial Organs (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9620952.3A GB9620952D0 (en) | 1996-10-09 | 1996-10-09 | Therapeutic drug delivery using mononuclear phagocytes |
| GBGB9701975.6A GB9701975D0 (en) | 1997-01-30 | 1997-01-30 | Targeting of stress inducible genes |
| GBGB9703670.1A GB9703670D0 (en) | 1997-02-21 | 1997-02-21 | Mononuclear phagocytes in therapeutic drug delivery |
| PCT/GB1997/002709 WO1998015294A1 (en) | 1996-10-09 | 1997-10-08 | Mononuclear phagocytes in therapeutic drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE290402T1 true ATE290402T1 (de) | 2005-03-15 |
Family
ID=27268510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97943993T ATE290402T1 (de) | 1996-10-09 | 1997-10-08 | Mononukleare phagozyten zur verabreichung von therapeutischen arzneimitteln |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7189562B2 (de) |
| EP (1) | EP0935471B1 (de) |
| JP (1) | JP2001501944A (de) |
| AT (1) | ATE290402T1 (de) |
| AU (1) | AU744090B2 (de) |
| CA (1) | CA2268417A1 (de) |
| DE (1) | DE69732710T2 (de) |
| GB (1) | GB2332434B (de) |
| NZ (1) | NZ334312A (de) |
| WO (1) | WO1998015294A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9705521D0 (en) * | 1997-03-18 | 1997-05-07 | Univ Sheffield | The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue |
| CA2303663A1 (en) * | 1997-09-23 | 1999-04-01 | Oxford Biomedica (Uk) Limited | Expression of genes in hematopoietic stem cells in hischaemic conditions |
| CN1319139A (zh) * | 1998-09-23 | 2001-10-24 | 牛津生物医学（英国）有限公司 | 多聚核苷酸构建体及其应用 |
| CA2418386A1 (en) * | 2000-08-07 | 2002-02-14 | Angiogenetics Sweden Ab | Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| GB0102946D0 (en) * | 2001-02-06 | 2001-03-21 | Oxford Biomedica Ltd | Enzyme |
| EP2004237A1 (de) * | 2006-04-03 | 2008-12-24 | Keele University | Gezielte therapie |
| US20100331819A1 (en) | 2009-06-24 | 2010-12-30 | Abbott Cardiovascular Systems Inc. | Drug Delivery System and Method of Treatment of Vascular Diseases Using Photodynamic Therapy |
| EP4593868A1 (de) * | 2022-09-26 | 2025-08-06 | Institut Curie | Myeloidzellen zur expression von il-2 und verwendungen davon zur schnellen antikrebstherapie |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2709309B1 (fr) * | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Compositions cellulaires, préparation et utilisations thérapeutiques. |
| GB9402857D0 (en) * | 1994-02-15 | 1994-04-06 | Isis Innovation | Targeting gene therapy |
| CA2186118C (en) * | 1994-03-23 | 2010-10-19 | Richard W. Hanson | Compacted nucleic acids and their delivery to cells |
| AU2268895A (en) | 1994-04-15 | 1995-11-16 | John Double Makavilitogia | An engine emission restrictor |
| WO1995029704A1 (en) * | 1994-04-28 | 1995-11-09 | Scott Freeman | Cell lines obtained by in vivo migration and by fusion with autoimmune cells |
| GB9705521D0 (en) | 1997-03-18 | 1997-05-07 | Univ Sheffield | The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue |
-
1997
- 1997-10-08 JP JP10517287A patent/JP2001501944A/ja active Pending
- 1997-10-08 GB GB9904144A patent/GB2332434B/en not_active Revoked
- 1997-10-08 AU AU45643/97A patent/AU744090B2/en not_active Ceased
- 1997-10-08 WO PCT/GB1997/002709 patent/WO1998015294A1/en not_active Ceased
- 1997-10-08 AT AT97943993T patent/ATE290402T1/de not_active IP Right Cessation
- 1997-10-08 US US09/284,009 patent/US7189562B2/en not_active Expired - Fee Related
- 1997-10-08 NZ NZ334312A patent/NZ334312A/xx unknown
- 1997-10-08 DE DE69732710T patent/DE69732710T2/de not_active Expired - Fee Related
- 1997-10-08 EP EP97943993A patent/EP0935471B1/de not_active Expired - Lifetime
- 1997-10-08 CA CA002268417A patent/CA2268417A1/en not_active Abandoned
-
2006
- 2006-10-04 US US11/543,760 patent/US20080118481A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998015294A1 (en) | 1998-04-16 |
| GB9904144D0 (en) | 1999-04-14 |
| NZ334312A (en) | 2000-10-27 |
| US20020061294A1 (en) | 2002-05-23 |
| EP0935471B1 (de) | 2005-03-09 |
| CA2268417A1 (en) | 1998-04-16 |
| AU744090B2 (en) | 2002-02-14 |
| GB2332434B (en) | 2001-04-04 |
| AU4564397A (en) | 1998-05-05 |
| EP0935471A1 (de) | 1999-08-18 |
| DE69732710D1 (de) | 2005-04-14 |
| JP2001501944A (ja) | 2001-02-13 |
| DE69732710T2 (de) | 2005-07-28 |
| US20080118481A1 (en) | 2008-05-22 |
| GB2332434A (en) | 1999-06-23 |
| US7189562B2 (en) | 2007-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE372146T1 (de) | System zur verabreichung von medikamenten mit veränderbarer rate | |
| DK1093383T3 (da) | Lægemiddelafgivelsessystem omfattende et homeobox-peptid og et cytotoksisk eller antineoplastisk lægemiddel | |
| PT932388E (pt) | Forma de dosagem e metodo para administracao de farmacos | |
| DE69922143D1 (de) | Implantierbares system mit medikamentenabgebenden zellen zur lokalen verabreichung von medikamenten bei bedarf | |
| DE59811840D1 (de) | Zusammensetzung zur therapie von diabetes mellitus und fettsucht | |
| ATE444768T1 (de) | Wirkstoffabgabesysteme | |
| CY1118206T1 (el) | Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη | |
| ATE343969T1 (de) | Beschichtete medizinische geräte | |
| DE69739165D1 (de) | Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe | |
| EP1374908A3 (de) | Polymere-Arzneimittel Konjugate die eine Hydrazidolinkergruppe enthalten | |
| BG103552A (bg) | Терапевтични средства | |
| DE3868037D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe. | |
| DE3676235D1 (de) | Arzneizubereitung mit verzoegerter wirkstoffabgabe. | |
| EA200401317A1 (ru) | Композиции и способы дозирования липосом определенных размеров для лечения или предотвращения заболевания | |
| EP0887075A3 (de) | Klebstoffmasse zur transdermalen Verabreichung von stark weichmachenden Wirkstoffen | |
| DE69807634D1 (de) | Medizinische einrichtung zur verabreichung von therapeutischen wirkstoffen | |
| WO2001087227A3 (en) | Drug containing polymeric micelles | |
| TR200002786T2 (tr) | Meloksikam için yeni galenik bir formülasyon. | |
| DE69820108D1 (de) | Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien | |
| DE69720055D1 (de) | Verabreichungsform zur abgabe von steigenden wirkstoffdosen | |
| WO2006022996A3 (en) | Dosage form containing multiple drugs | |
| EP0979225A4 (de) | Verbindungen und zubereitungen zur verabreichung aktiver mittel | |
| DE69732710D1 (de) | Mononukleare phagozyten zur verabreichung von therapeutischen arzneimitteln | |
| DK1112739T3 (da) | Langtidsafgivende depot-præparat | |
| BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0935471 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |